Results 231 to 240 of about 170,525 (342)

Pioglitazone and bariatric surgery are the most effective treatments for non‐alcoholic steatohepatitis: A hierarchical network meta‐analysis [PDF]

, 2020
Simona Panunzi, Sabina Maltese, Ornella Verrastro, Luca L’Abbate, Andrea De Gaetano, Maurizio Pompili, Esmeralda Capristo, Stefan R. Bornstein, Geltrude Mingrone   +8 more
openalex   +1 more source

Novel prolyl endopeptidase inhibitor from <i>Myricaria germanica</i> alleviates steatohepatitis. [PDF]

RSC Adv
Ullah K, Azam T, Sammad A, Ahmed T, Wadood A, Ali MF, Mushraf GM, Shaheen Siddiqui B, Li YX.   +8 more
europepmc   +1 more source

Intracellular cholesterol transporters and modulation of hepatic lipid metabolism: implications for diabetic dyslipidaemia and steatosis [PDF]

, 2014
Caridis, Anna-Maria, Dolan, Sharron, Graham, Annette, Soffientini, Ugo   +3 more
core   +1 more source

Prevalence and characteristics of metabolic dysfunction-associated steatohepatitis among pediatric patients in the MarketScan Databases. [PDF]

PLoS One
Peter-Marske KM, Zhang X, Wang T, Liu X, Fernandes G, Engel SS, Shankar R.   +6 more
europepmc   +1 more source

Aluminium nanoparticles (AL-NPs) caused gastrointestinal malformations, metabolic disorders and steatohepatitis in zebrafish larvae: Modulatory role of rosmarinic acid

Suzan Attia Mawed, Mervat H. Ghoneim, Mayada R. Farag, Marwa S.H. Abdelmoety, Tamer Ahmed Ismail, Sheren A. Al-Zahaby   +5 more
openalex   +1 more source

Primary Care Utilization, Preventative Screening, and Control of Metabolic Syndrome in Metabolic Dysfunction-Associated Steatohepatitis Liver Transplant Recipients [PDF]

Sarah Flynn, Varun Saxena, Danielle Brandman   +2 more
openalex   +1 more source

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.

The Lancet, 2019
Z. Younossi, V. Ratziu, R. Loomba, M. Rinella, Q. Anstee, Z. Goodman, P. Bedossa, A. Geier, S. Beckebaum, P. Newsome, D. Sheridan, M. Sheikh, J. Trotter, W. Knapple, E. Lawitz, M. Abdelmalek, K. Kowdley, A. Montaño-Loza, J. Boursier, P. Mathurin, E. Bugianesi, G. Mazzella, A. Olveira, H. Cortez‐Pinto, I. Graupera, D. Orr, L. Gluud, J. Dufour, D. Shapiro, J. Campagna, L. Zaru, L. Macconell, R. Shringarpure, S. Harrison, A. Sanyal   +34 more
semanticscholar   +1 more source

LIPOTOXICITY PLAYS A KEY ROLE IN THE DEVELOPMENT OF ANGIOGENESIS AND MICROCIRCULATORY MODULATION IN MASLD SPECTRUM. [PDF]

Arq Gastroenterol
Hirayama AB, Taliberti IB, Oliveira CPMS, Alves VAF.   +3 more
europepmc   +1 more source

Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis

, 2004
Chikako Namikawa, Shuping Zhang, John Raynor Vyselaar, Yasuko Nozaki, Yoshihisa Nemoto, Masafumi Ono, Naoaki Akisawa, Toshiji Saibara, Makoto Hiroi, Hideaki Enzan, Saburo Onishi   +10 more
openalex   +1 more source

P4‐ATPases as Phospholipid Flippases: From Membrane Dynamics to Human Disorders

Medicine Bulletin, EarlyView.
ABSTRACT P4‐ATPases (P4 subfamily of P‐type ATPases) flippase complex includes an α‐subunit responsible for catalysis and a supporting β‐subunit, which consumes energy by catalyzing the hydrolysis of ATP, thereby facilitating the translocation of aminophospholipids from the outer to the inner leaflet of cellular membranes to maintain the asymmetric ...
Guangyi Chen, Yeming Yang, Xianjun Zhu
wiley   +1 more source